Results 31 to 40 of about 4,444,377 (217)

VHL (von Hippel-Lindau tumor suppressor) [PDF]

open access: yes, 2002
Review on VHL (von Hippel-Lindau tumor suppressor), with data on DNA, on the protein encoded, and where the gene is ...
Richard, S
core   +1 more source

Peripheral retinal nonperfusion using widefield imaging with von Hippel-Lindau disease

open access: yesInternational Journal of Retina and Vitreous, 2018
Background To describe a case of von Hippel-Lindau disease with peripheral retinal nonperfusion. Case presentation A 66-year-old female with known cerebellar and midbrain hemangioblastomas was evaluated for a retinal hemangioblastoma in the right eye ...
Jose S. Pulido   +5 more
doaj   +1 more source

A Case of Von Hippel–Lindau Disease with Bilateral Pheochromocytoma and Ectopic Hypersecretion of Intact Parathyroid Hormone in an Adolescent Girl

open access: yesCase Reports in Endocrinology, 2020
Von Hippel–Lindau disease is an autosomal dominant inherited syndrome predisposing to a variety of highly vascularised tumors in different organs.
Rym Belaid   +5 more
doaj   +1 more source

Obstructive azoospermia secondary to bilateral epididymal cystadenomas in a patient with von Hippel-Lindau

open access: yesUrology Case Reports, 2019
von Hippel-Lindau (VHL) is a heritable cancer syndrome associated with findings in multiple organ systems. Male patients can be affected by epididymal cystadenomas which are benign tumors localized to the epididymis.
Patrick T. Gomella   +4 more
doaj   +1 more source

Bone and Soft Tissue Neoplasms in Infants Versus Older Children: A Report From the Cancer in Young People in Canada Program

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine   +21 more
wiley   +1 more source

Hemangioblastomas aparentemente esporádicos e doença de von Hippel-Lindau não suspeita

open access: yesBrazilian Neurosurgery, 2008
Objetivo: Apresentar os achados associados à doença de von Hippel-Lindau em pacientes portadores de hemangioblastoma do sistema nervoso central, aparentemente esporádico, submetidos a rastreamento (screening) em um centro neurocirúrgico de referência ...
Rogelio Iván Ortiz-Velázquez   +5 more
doaj   +1 more source

Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy

open access: yesFEBS Letters, EarlyView.
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley   +1 more source

von Hippel-Lindau Disease

open access: yesMedicine, 1997
von Hippel-Lindau disease is a hereditary cancer syndrome characterized by the development of vascular tumors of the central nervous system and retina, clear cell renal carcinomas, pheochromocytomas, pancreatic islet cell tumors, endolymphatic sac tumors, and benign cysts affecting a variety of organs. VHL disease is caused by germline mutations of the
E R, Maher, W G, Kaelin
openaire   +2 more sources

Von Hippel-Lindau disease

open access: yesInternational Journal of Surgery Case Reports, 2022
ABSTRACT Introduction and importance: Von Hippel-Lindau (VHL) disease is a rare autosomal dominantly inherited genetic condition. Von Hippel characterized the illness independently in 1911, and Lindau in 1926. Its prevalence is estimated to be about 1 in every 36,000 live births.
Neupane, Durga   +5 more
openaire   +2 more sources

The interaction of Notch signalling, haemodynamic flow and angiogenesis in Von Hippel-Lindau mutant zebrafish. [PDF]

open access: yes, 2013
Introduction: There is increasing evidence that the endothelium is able to transduce circulatory force into signals which influence angiogenic behaviour.
Watson, Oliver
core   +4 more sources

Home - About - Disclaimer - Privacy